An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies.

E.P. Mauser-Bunschoten; I. Kleine Budde; S. Lopaciuk; M.M.W. Koopman; F.J.M van der Meer; I.R.O. Novakova; P. Ypma; P.W.G. van der Linden; J. Windyga; P.F.W. Strengers

An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies.

E.P. Mauser-Bunschoten
, I. Kleine Budde
, S. Lopaciuk
, M.M.W. Koopman
, F.J.M van der Meer
, I.R.O. Novakova
, P. Ypma
, P.W.G. van der Linden
, J. Windyga
, P.F.W. Strengers

Research output: Contribution to journal › Article › Academic › peer-review

Original language	English
Pages (from-to)	439-445
Number of pages	7
Journal	Haemophilia
Volume	17
Issue number	3
Publication status	Published - 2011

Cite this

@article{13e4cd973b4f47e29389af5e66259bfb,

title = "An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact{\textregistered}), results of phase III and IV clinical studies.",

author = "E.P. Mauser-Bunschoten and \{Kleine Budde\}, I. and S. Lopaciuk and M.M.W. Koopman and \{van der Meer\}, F.J.M and I.R.O. Novakova and P. Ypma and \{van der Linden\}, P.W.G. and J. Windyga and P.F.W. Strengers",

year = "2011",

language = "English",

volume = "17",

pages = "439--445",

journal = "Haemophilia",

issn = "1351-8216",

publisher = "John Wiley \& Sons Inc.",

number = "3",

}

TY - JOUR

T1 - An ultrapure plasma-derived monoclonal antibody-purified factor IX concentrate (Nonafact®), results of phase III and IV clinical studies.

AU - Mauser-Bunschoten, E.P.

AU - Kleine Budde, I.

AU - Lopaciuk, S.

AU - Koopman, M.M.W.

AU - van der Meer, F.J.M

AU - Novakova, I.R.O.

AU - Ypma, P.

AU - van der Linden, P.W.G.

AU - Windyga, J.

AU - Strengers, P.F.W.

PY - 2011

Y1 - 2011

M3 - Article

SN - 1351-8216

VL - 17

SP - 439

EP - 445

JO - Haemophilia

JF - Haemophilia

IS - 3

ER -